Parker Waichman LLP

Approved Epilepsy Drugs Suicide Warnings

  Epilepsy Drugs May Cause Suicidal Thoughts. Federal regulators have approved new suicide warnings for more than two dozen epilepsy drugs. The Food & Drug Administration (FDA) had ordered the label update last December, when it issued a public-health advisory regarding the association between epilepsy drugs and suicidal thoughts and behavior. The new suicide warnings […]

Epilepsy Drugs

 

Epilepsy Drugs May Cause Suicidal Thoughts. Federal regulators have approved new suicide warnings for more than two dozen epilepsy drugs. The Food & Drug Administration (FDA) had ordered the label update last December, when it issued a public-health advisory regarding the association between epilepsy drugs and suicidal thoughts and behavior.

The new suicide warnings will appear on the labeling of Carbatrol, Celontin, Depakene, Depakote ER, Depakote sprinkles, Depakote tablets, Dilantin, Equetro, Felbatol, Gabitril, Keppra, Keppra XR, Klonopin, Lamictal, Lyrica, Mysoline, Neurontin, Peganone, Stavzor, Tegretol, Tegretol XR, Topamax, Tranxene, Tridione, Trileptal, Zarontin, Zonegran, as well as their generic equivalents, the FDA said.

the new warnings resulted from the FDA’s review of 199 clinical trials of 11 antiepileptic drugs

In addition to epilepsy, some of these drugs are used to treat psychiatric disorders, migraine headaches and other conditions.

As we reported in December, the new warnings resulted from the FDA’s review of 199 clinical trials of 11 antiepileptic drugs which showed that patients receiving antiepileptic drugs had almost twice the risk of suicidal behavior or thoughts (0.43 percent) compared to patients receiving a placebo (0.24 percent). This difference was about one additional case of suicidal thoughts or behaviors for every 500 patients treated with antiepileptic drugs instead of placebo, the agency said.

Since December, the agency has been working with drug makers to determine the appropriate labeling.  The revised labels were approved on April 23, the FDA said.

The FDA said comprehensive Medication Guides are being developed

In addition to the revised labels, new comprehensive Medication Guides have been approved for Lamictal, Lyrica, Topamax, Zonegran and Keppra. The FDA said comprehensive Medication Guides are being developed for the other drugs and should be available by the end of 2009.

According to the FDA, if suicidal thoughts or behavior emerges in patient during treatment with any of the affected epilepsy drugs, prescribers should consider whether these symptoms may be related to the illness being treated. All patients who currently are taking or starting on any antiepileptic drug for any indication should be monitored for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression.

Need Legal Help Regarding Epilepsy Drugs?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
My husband and I would like to personally thank Ashley Lopilato and Parker Waichman for their assistance in having a successful outcome through a long and very difficult process. It was a relief to have Ashley and the staff follow-up on the status of our claim and keeping us informed. It was worth the wait! We recommend Parker Waichman to handle your legal needs.
Yolanda Quinones
3 years ago
5 Star Reviews 150
Positive: Professionalism , Responsiveness B Rollis was very kind, helpful and quickly returned calls regarding any questions I had.
Willie Matos
3 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value PW already a reputable Law Firm still exceeded my expectations. PW did an outstanding job.
Charles Jones
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038